Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation
Top Cited Papers
- 1 January 2015
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 148 (1), 108-117
- https://doi.org/10.1053/j.gastro.2014.10.001
Abstract
No abstract availableKeywords
Funding Information
- Gilead Sciences
This publication has 26 references indexed in Scilit:
- Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experienceJournal of Hepatology, 2013
- Treatment of recurrent HCV infection following liver transplantation: Results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirinJournal of Hepatology, 2012
- Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirinJournal of Hepatology, 2008
- Clinical Benefits of Antiviral Therapy in Patients with Recurrent Hepatitis C Following Liver TransplantationAmerican Journal of Transplantation, 2008
- Efficacy of Antiviral Therapy on Hepatitis C Recurrence After Liver Transplantation: A Randomized Controlled StudyGastroenterology, 2007
- Interferon-Based Combination Anti-Viral Therapy for Hepatitis C Virus After Liver Transplantation: A Review and Quantitative AnalysisAmerican Journal of Transplantation, 2006
- Benefit of Sustained Virological Response to Combination Therapy on Graft Survival of Liver Transplanted Patients with Recurrent Chronic Hepatitis CAmerican Journal of Transplantation, 2005
- Interferon-α 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomized studyGastroenterology, 2003
- Hepatitis C virus kinetics during and immediately after liver transplantationHepatology, 2002
- High Incidence of Allograft Cirrhosis in Hepatitis C Virus Genotype 1B Infection Following Transplantation: Relationship With Rejection EpisodesHepatology, 1999